Dataset Information

Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas.

ABSTRACT: B cells have the unique property to somatically alter their immunoglobulin (IG) genes by V(D)J recombination, somatic hypermutation (SHM) and class-switch recombination (CSR). Aberrant targeting of these mechanisms is implicated in lymphomagenesis, but the mutational processes are poorly understood. By performing whole genome and transcriptome sequencing of 181 germinal center derived B-cell lymphomas (gcBCL) we identified distinct mutational signatures linked to SHM and CSR. We show that not only SHM, but presumably also CSR causes off-target mutations in non-IG genes. Kataegis clusters with high mutational density mainly affected early replicating regions and were enriched for SHM- and CSR-mediated off-target mutations. Moreover, they often co-occurred in loci physically interacting in the nucleus, suggesting that mutation hotspots promote increased mutation targeting of spatially co-localized loci (termed hypermutation by proxy). Only around 1% of somatic small variants were in protein coding sequences, but in about half of the driver genes, a contribution of B-cell specific mutational processes to their mutations was found. The B-cell-specific mutational processes contribute to both lymphoma initiation and intratumoral heterogeneity. Overall, we demonstrate that mutational processes involved in the development of gcBCL are more complex than previously appreciated, and that B cell-specific mutational processes contribute via diverse mechanisms to lymphomagenesis.

SUBMITTER: Hubschmann D

PROVIDER: S-EPMC8257491 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas.

Hübschmann Daniel D Kleinheinz Kortine K Wagener Rabea R Bernhart Stephan H SH López Cristina C Toprak Umut H UH Sungalee Stephanie S Ishaque Naveed N Kretzmer Helene H Kreuz Markus M Waszak Sebastian M SM Paramasivam Nagarajan N Ammerpohl Ole O Aukema Sietse M SM Beekman Renée R Bergmann Anke K AK Bieg Matthias M Binder Hans H Borkhardt Arndt A Borst Christoph C Brors Benedikt B Bruns Philipp P Carrillo de Santa Pau Enrique E Claviez Alexander A Doose Gero G Haake Andrea A Karsch Dennis D Haas Siegfried S Hansmann Martin-Leo ML Hoell Jessica I JI Hovestadt Volker V Huang Bingding B Hummel Michael M Jäger-Schmidt Christina C Kerssemakers Jules N A JNA Korbel Jan O JO Kube Dieter D Lawerenz Chris C Lenze Dido D Martens Joost H A JHA Ott German G Radlwimmer Bernhard B Reisinger Eva E Richter Julia J Rico Daniel D Rosenstiel Philip P Rosenwald Andreas A Schillhabel Markus M Stilgenbauer Stephan S Stadler Peter F PF Martín-Subero José I JI Szczepanowski Monika M Warsow Gregor G Weniger Marc A MA Zapatka Marc M Valencia Alfonso A Stunnenberg Hendrik G HG Lichter Peter P Möller Peter P Loeffler Markus M Eils Roland R Klapper Wolfram W Hoffmann Steve S Trümper Lorenz L Küppers Ralf R Schlesner Matthias M Siebert Reiner R

Leukemia 20210505 7

B cells have the unique property to somatically alter their immunoglobulin (IG) genes by V(D)J recombination, somatic hypermutation (SHM) and class-switch recombination (CSR). Aberrant targeting of these mechanisms is implicated in lymphomagenesis, but the mutational processes are poorly understood. By performing whole genome and transcriptome sequencing of 181 germinal center derived B-cell lymphomas (gcBCL) we identified distinct mutational signatures linked to SHM and CSR. We show that not on ...[more]

PMID: 33953289

Similar Datasets

Project description:B-cell non-Hodgkin lymphomas (B-NHLs) are highly heterogenous by genetic, phenotypic, and clinical appearance. Next-generation sequencing technologies and multi-dimensional data analyses have further refined the way these diseases can be more precisely classified by specific genomic, epigenomic, and transcriptomic characteristics. The molecular and genetic heterogeneity of B-NHLs may contribute to the poor outcome of some of these diseases, suggesting that more personalized precision-medicine approaches are needed for improved therapeutic efficacy. The germinal center (GC) B-cell like diffuse large B-cell lymphomas (GCB-DLBCLs) and follicular lymphomas (FLs) share specific epigenetic programs. These diseases often remain difficult to treat and surprisingly do not respond advanced immunotherapies, despite arising in secondary lymphoid organs at sites of antigen recognition. Epigenetic dysregulation is a hallmark of GCB-DLBCLs and FLs, with gain-of-function (GOF) mutations in the histone methyltransferase EZH2, loss-of-function (LOF) mutations in histone acetyl transferases CREBBP and EP300, and the histone methyltransferase KMT2D representing the most prevalent genetic lesions driving these diseases. These mutations have the common effect to disrupt the interactions between lymphoma cells and the immune microenvironment, via decreased antigen presentation and responsiveness to IFN-γ and CD40 signaling pathways. This indicates that immune evasion is a key step in GC B-cell lymphomagenesis. EZH2 inhibitors are now approved for the treatment of FL and selective HDAC3 inhibitors counteracting the effects of CREBBP LOF mutations are under development. These treatments can help restore the immune control of GCB lymphomas, and may represent optimal candidate agents for more effective combination with immunotherapies. Here, we review recent progress in understanding the impact of mutant chromatin modifiers on immune evasion in GCB lymphomas. We provide new insights on how the epigenetic program of these diseases may be regulated at the level of metabolism, discussing the role of metabolic intermediates as cofactors of epigenetic enzymes. In addition, lymphoma metabolic adaptation can negatively influence the immune microenvironment, further contributing to the development of immune cold tumors, poorly infiltrated by effector immune cells. Based on these findings, we discuss relevant candidate epigenetic/metabolic/immune targets for rational combination therapies to investigate as more effective precision-medicine approaches for GCB lymphomas.

Dataset Information

Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas.

Publications

Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets